Tobramycin 300 mg Once-a-day (o.d.) Aerosol in Adults With Cystic Fibrosis
Condition(s):Cystic FibrosisLast Updated:July 24, 2012Completed
Hide Studies Not Open or Pending
Condition(s):Cystic FibrosisLast Updated:July 24, 2012Completed
Condition(s):Cystic Fibrosis; Rhinosinusitis; Lung DiseasesLast Updated:February 15, 2023Terminated
Condition(s):Orthopedic OperationsLast Updated:September 11, 2013Completed
Condition(s):Antibotics in Cementless KneesLast Updated:October 5, 2021Completed
Condition(s):Breast CancerLast Updated:December 22, 2022Active, not recruiting
Condition(s):Cystic FibrosisLast Updated:July 24, 2012Completed
Condition(s):Ventilator Associated Pneumonia (VAP)Last Updated:August 18, 2021Completed
Condition(s):Cystic FibrosisLast Updated:March 29, 2017Terminated
Condition(s):Cystic FibrosisLast Updated:May 7, 2007Completed
Condition(s):Bronchiectasis Adult; Pseudomonas InfectionsLast Updated:August 2, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.